A PET/CT PSMA exam is an advanced imaging test used primarily for detecting and managing prostate cancer. It provides detailed images of the body, helping identify cancerous cells with …
Additional agents are being evaluated in phase III trials in the United States, including 18F- PSMA-1007 (NCT04239742 and NCT04487847), 18F-rhPSMA-7.3 (NCT04186819 and …
There is insufficient evidence regarding prostate-specific membrane antigen (PSMA) radiotracers for imaging (PET or PET/CT) compared to alternative tests for improving health outcomes in …
AUC INTRODUCTION membrane antigen (PSMA) imaging for prostate Nuclear medicine imaging studies are essential for the cancer. This document is presented to assist health-diagnosis and …
With the anticipated approval of PSMA-based RLTs, given the results of the VISION study, PSMA PET will likely have an important role in this disease setting, and the scoring of this indi-cation …
The study compared Ga-68 PSMA-11 PET/CT with conventional imaging (CT, MRI, bone scans) and used histopathology from prostatectomy as the reference standard.
What is PSMA and how long has it been available? PSMA, or prostate specific membrane antigen, is a protein that sits primarily on the surface of the prostate cancer cell. Research …